Annet G.H. Roodvoets

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.5K citations · Full text

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +9

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

A.J. Breugom, W. van Gijn, E.W. Muller et al. · Annals of Oncology · 2014 · 383 citations · Full text

Rectal Cancer Patients, Surgical Oncology, Radiation Therapy +10

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery

Esmée A. Dijkstra, Per J. Nilsson, Geke A.P. Hospers et al. · Annals of Surgery · 2023 · 309 citations · Full text

Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial

Maxime J.M. van der Valk, Corrie A.M. Marijnen, Boudewijn van Etten et al. · Radiotherapy and Oncology · 2020 · 205 citations · Full text

Adaptive Radiotherapy, Preoperative Chemotherapy, Surgical Oncology +8

Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study

Laura M. Fernández, Guilherme Pagin São Julião, Nuno Figueiredo et al. · The Lancet Oncology · 2020 · 202 citations · Full text

International Watch, Surgical Oncology, Conditional Recurrence-free Survival +11